Nektar therapeutics

Major-Pharmaceuticals

NKTR


455 Mission Bay Boulevard South
San Francisco , CA 94158

Executive/
Director

Price

  • Last Close
  • $ 1.12
    $ +0.15 15.7 %
    Jan 3, 2025
  • 52-Week High/Low
  • $1.66 - $0.42
  • YTD
  • 0%

  • Trading Volume
  • 113,940
  • Market Cap Full
  • $ 213.7M
  • Shares Outstanding
  • 190.8M
    Oct 31, 2023
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 91.3% 77.9% 2.2% -5% 17.9% -59.8% -68.9% 63.7% 20% -
Q2 -16.7% -50.6% 3.6% 4% -14.4% -30% -18.2% 26.9% - -
Q3 22.8% 24.8% -49.7% 8% 5% -15.8% 3.7% -6.3% - -
Q4 141.1% -42% 17.1% 2.5% -25.1% -29.4% -0.9% -32.9% - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 20% - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    -27%387%-45%-35%-20%-21%-83%-75%65%20%0%

Earnings

2017 2018 2019 2020 2021 2022 2023
Q1 0.42 -0.6 -0.68 -0.78 -0.68 -0.49 -0.73
Q2 0.39 5.33 -0.63 -0.45 -0.69 -0.85 -0.27
Q3 0.37 -0.56 -0.56 -0.61 -0.7 -0.31 -0.24
Q4 0.14 -0.39 -0.64 -0.65 -0.79 -0.32 -
A 1.3 3.8 -2.5 -2.5 -2.9 -2 -1.24

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 174.1 177.6 182.2 186.3 189.2
Jun 171.4 174.3 178 182.3 186.3 189.2
Sep 172.5 175.3 178.9 183.8 187.4 190.1
Dec 173.1 175.9 179.4 184.6 188 190.8

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.2 1.6 1.3 1.6 2.2
Fixed Asset Turnover 2.7 0.8 0.8 0.3 1.9
Total Asset Turnover 0.1 0.1 0.1 0.1 0.6
Leverage
Interest Coverage 47 -5.7 -22.4 -440 98.3
Debt Ratio - - - - 0.2
Debt – Equity Ratio - - - - 0.1
Equity multiplier 0.1 0.2 0.2 0.3 0.4